| calcium channel, voltage-dependent, gamma subunit 6 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | MICONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.788uM | 3.683uM | View | 
          
            
                | prostaglandin-endoperoxide synthase 1 | KETOPROFEN | Cyclooxygenase COX-1 | 89% | .014uM | NoneNone | View | 
          
            
                | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | KETOPROFEN | Cyclooxygenase COX-1 | 89% | .014uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | amiloride-sensitive cation channel 5, intestinal | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type III, beta | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type VIII, alpha polypeptide | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type 10, alpha polypeptide | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha polypeptide | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha polypeptide | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 gamma | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 beta | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type 2, alpha 1 polypeptide | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type XI, alpha | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | PERGOLIDE | Sodium Channel, Site 2 | 88% | 1.728uM | 1.577uM | View | 
          
            
                | phosphodiesterase 4A, cAMP specific | GW-1929 | Phosphodiesterase PDE4 | 88% | 7.45uM | NoneNone | View | 
          
            
                | phosphodiesterase 4C, cAMP-specific | GW-1929 | Phosphodiesterase PDE4 | 88% | 7.45uM | NoneNone | View | 
          
            
                | phosphodiesterase 4D | GW-1929 | Phosphodiesterase PDE4 | 88% | 7.45uM | NoneNone | View | 
          
            
                | phosphodiesterase 4B, cAMP specific | GW-1929 | Phosphodiesterase PDE4 | 88% | 7.45uM | NoneNone | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | CYPROHEPTADINE | Calcium Channel Type L, Phenylalkylamine | 88% | .438uM | .426uM | View | 
          
            
                | Protein-tyrosine kinase, Fyn | PERHEXILINE | Protein Tyrosine Kinase, Fyn | 88% | 4.064uM | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 2a | HEXACHLOROPHENE | Adrenergic alpha2A | 88% | 5.4965uM | 2.0612uM | View | 
          
            
                | epidermal growth factor receptor | MONTELUKAST | Protein Tyrosine Kinase, EGF Receptor | 88% | 3.197uM | NoneNone | View | 
          
            
                | cholinergic receptor, muscarinic 1 | FLUNARIZINE | Muscarinic M1 | 88% | 2.936uM | .707uM | View | 
          
            
                | adrenergic receptor, alpha 2a | EPINEPHRINE | Imidazoline I2, Central | 88% | .232uM | .154uM | View | 
          
            
                | adrenergic receptor, alpha 2c (Non-specific probe) | EPINEPHRINE | Imidazoline I2, Central | 88% | .232uM | .154uM | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | CYCLIZINE | Dopamine Transporter | 88% | .763uM | .606uM | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | MOSAPRIDE | CYP450-3A4 Inhibition | 88% | .7uM | NoneNone | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | RAPAMYCIN | CYP450-3A4 Inhibition | 88% | 2uM | NoneNone | View | 
          
            
                | cytochrome P450, family 3, subfamily a, polypeptide 13 | RESVERATROL | CYP450-3A4 Inhibition | 88% | .6uM | NoneNone | View | 
          
            
                | Cytochrom P450-2D6 monooxygenase | PHENYLHYDRAZINE | CYP450-2D6 Inhibition | 88% | 3uM | NoneNone | View | 
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | IDEBENONE | CYP450-2C9 Inhibition | 88% | 5uM | NoneNone | View | 
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | IDEBENONE | CYP450-2C9 Inhibition | 88% | 5uM | NoneNone | View | 
          
            
                | opioid receptor, sigma 1 | BUFLOMEDIL | Sigma1 | 88% | 2.1705uM | .9122uM | View | 
          
            
                | Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) | BITHIONOL | CYP450-2C9 Inhibition | 88% | NoneNone | NoneNone | View | 
          
            
                | cytochrome P450, family 2, subfamily C, polypeptide 9 | BITHIONOL | CYP450-2C9 Inhibition | 88% | NoneNone | NoneNone | View | 
          
            
                | prostaglandin-endoperoxide synthase 2 | TENIDAP | Cyclooxygenase COX-2 | 88% | .267uM | NoneNone | View | 
          
            
                | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | TENIDAP | Cyclooxygenase COX-2 | 88% | .267uM | NoneNone | View | 
          
            
                | epidermal growth factor receptor | METHYLDOPA | Protein Tyrosine Kinase, EGF Receptor | 88% | 5.228uM | NoneNone | View | 
          
            
                | melanocortin 4 receptor | GRAMICIDIN | Melanocortin MC4 | 88% | 3.313uM | 3.186uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage gated, type VIII, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type III, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type II, beta | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type II, alpha 2 | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type I, beta | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | sodium channel, voltage-gated, type I, alpha | PROMETHAZINE | Sodium Channel, Site 2 | 86% | 2.37uM | 2.162uM | View | 
          
            
                | A3 adenosine receptor | RABEPRAZOLE | Adenosine A3 | 86% | 3.219uM | 1.82uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | PROMETHAZINE | Calcium Channel Type L, Benzothiazepine | 86% | 2.779uM | 2.47uM | View | 
          
            
                | adrenergic receptor, alpha 2b | RABEPRAZOLE | Adrenergic alpha2B | 86% | 1.737uM | .793uM | View | 
          
            
                | adrenergic receptor, alpha 1b | RALOXIFENE | Adrenergic alpha1B | 86% | 2.693uM | 1.491uM | View | 
          
            
                | adrenergic receptor, alpha 2a | BENZETHONIUM CHLORIDE | Adrenergic alpha2A | 86% | 3.102uM | 1.163uM | View | 
          
            
                | thromboxane A synthase 1 | SB-203580 | Thromboxane Synthetase | 86% | .494uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | SB-203580 | Thromboxane Synthetase | 86% | .494uM | NoneNone | View | 
          
            
                | dopamine receptor 2 | ASTEMIZOLE | Dopamine D2L | 86% | 4.521uM | 1.507uM | View | 
          
            
                | caspase 1 | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | caspase 3, apoptosis related cysteine protease | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | caspase 2 | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | caspase 7 | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | caspase 6 | TRIAMTERENE | Protease, Caspase 1 | 86% | 3.663uM | NoneNone | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | TRAZODONE | Adrenergic alpha1D | 86% | .265uM | .13uM | View | 
          
            
                | adrenergic receptor, alpha 1b | GENTIAN VIOLET | Adrenergic alpha1B | 86% | 3.595uM | 1.99uM | View | 
          
            
                | A3 adenosine receptor | GENTIAN VIOLET | Adenosine A3 | 86% | 4.166uM | 2.355uM | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2B | ISOTRETINOIN | Serotonin 5-HT2B | 86% | .848uM | .54uM | View | 
          
            
                | adrenergic receptor, alpha 2a | METHYSERGIDE | Adrenergic alpha2A | 86% | 1.631uM | .611uM | View | 
          
            
                | 5-hydroxytryptamine receptor 6 | MEPAZINE | Serotonin 5-HT6 | 86% | 1.837uM | .853uM | View | 
          
            
                | opioid receptor, sigma 1 | LOPERAMIDE | Sigma1 | 86% | .628uM | .264uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, gamma | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, delta | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, nonvoltage-gated 1 alpha | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage-gated, type X, alpha | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage-gated, type IX, alpha | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage gated, type VIII, alpha | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage-gated, type VII, alpha | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | sodium channel, voltage-gated, type IV, beta | MEPAZINE | Sodium Channel, Site 2 | 85% | 2.521uM | 2.3uM | View | 
          
            
                | mitogen activated protein kinase 14 | 1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE | Protein Serine/Threonine Kinase, p38alpha | 85% | .833uM | NoneNone | View | 
          
            
                | mitogen-activated protein kinase 14 | 1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE | Protein Serine/Threonine Kinase, p38alpha | 85% | .833uM | NoneNone | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | LEFLUNOMIDE | Dopamine Transporter | 85% | 2.884uM | 2.291uM | View | 
          
            
                | cholinergic receptor, muscarinic 2 | L-744832 | Muscarinic M2 | 85% | 3.568uM | 1.268uM | View | 
          
            
                | adrenergic receptor, alpha 1d (Non-specific probe) | QUINACRINE | Adrenergic alpha1D | 85% | 2.065uM | 1.015uM | View | 
          
            
                | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) | ACECLOFENAC | Aldose Reductase | 85% | 1.288uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | ACECLOFENAC | Aldose Reductase | 85% | 1.288uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 1, member B4 (aldose reductase) | ACECLOFENAC | Aldose Reductase | 85% | 1.288uM | NoneNone | View | 
          
            
                | aldo-keto reductase family 1, member B1 (aldose reductase) | ACECLOFENAC | Aldose Reductase | 85% | 1.288uM | NoneNone | View | 
          
            
                | adenine nucleotide translocase (DBSS) (Non-specific probe) | NIMODIPINE | Adenosine Transporter | 85% | 1.266uM | .433uM | View | 
          
            
                | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | NIMODIPINE | Adenosine Transporter | 85% | 1.266uM | .433uM | View | 
          
            
                | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 | NIMODIPINE | Adenosine Transporter | 85% | 1.266uM | .433uM | View | 
          
            
                | concentrative Na+ nucleoside cotransporter (DBSS) | NIMODIPINE | Adenosine Transporter | 85% | 1.266uM | .433uM | View | 
          
            
                | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | NIMODIPINE | Adenosine Transporter | 85% | 1.266uM | .433uM | View | 
          
            
                | histamine receptor H 1 | ORPHENADRINE | Histamine H1, Central | 85% | 1.241uM | .144uM | View | 
          
            
                | acetylcholinesterase (YT blood group) | EBASTINE | Acetylcholinesterase | 85% | 7.4799uM | NoneNone | View | 
          
            
                | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase | EBASTINE | Acetylcholinesterase | 85% | 7.4799uM | NoneNone | View | 
          
            
                | acetylcholinesterase | EBASTINE | Acetylcholinesterase | 85% | 7.4799uM | NoneNone | View | 
          
            
                | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | DESLORATADINE | Adrenergic, Norepinephrine Transporter | 85% | 1.116uM | 1.107uM | View | 
          
            
                | A3 adenosine receptor | CLOMIPHENE | Adenosine A3 | 85% | 5.35uM | 3.024uM | View | 
          
            
                | epidermal growth factor receptor | ASTEMIZOLE | Protein Tyrosine Kinase, EGF Receptor | 85% | 6.057uM | NoneNone | View | 
          
            
                | Cytochrom P450-2C19 monooxygenase | FINASTERIDE | CYP450-2C19 Inhibition | 85% | 1uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2C | DIPHENHYDRAMINE | Serotonin 5-HT2C | 85% | .98uM | .513uM | View | 
          
            
                | adenosine A2a receptor | OXFENDAZOLE | Adenosine A2A | 85% | 1.504uM | .844uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 8 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 7 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | TAMOXIFEN | Calcium Channel Type L, Dihydropyridine | 85% | 8.585uM | 5.519uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 6 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 5 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 4 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 3 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 2 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, gamma subunit 1 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 4 subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 3 subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 2 subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1S subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha 1F subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1D subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1C subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, beta 1 subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, L type, alpha 1E subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, N type, alpha 1B subunit | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | calcium channel, voltage-dependent, alpha2/delta subunit 1 | ECONAZOLE | Calcium Channel Type L, Phenylalkylamine | 89% | 3.014uM | 2.93uM | View | 
          
            
                | arachidonate 15-lipoxygenase | KETOCONAZOLE | Lipoxygenase 15-LO | 89% | 5.425uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase, second type | KETOCONAZOLE | Lipoxygenase 15-LO | 89% | 5.425uM | NoneNone | View | 
          
            
                | arachidonate 15-lipoxygenase | KETOCONAZOLE | Lipoxygenase 15-LO | 89% | 5.425uM | NoneNone | View | 
          
            
                | 5-hydroxytryptamine (serotonin) receptor 2A | FENOFIBRATE | Serotonin 5-HT2A | 89% | 2.118uM | .605uM | View | 
          
            
                | opioid receptor, sigma 1 | DEXCHLORPHENIRAMINE | Sigma1 | 89% | 1.658uM | .697uM | View | 
          
            
                | thromboxane A synthase 1 | SULCONAZOLE | Thromboxane Synthetase | 89% | .183uM | NoneNone | View | 
          
            
                | thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) | SULCONAZOLE | Thromboxane Synthetase | 89% | .183uM | NoneNone | View |